'Polypill' for heart failure cuts hospitalizations and ER visits by 60% in trial
medicalxpress - A "polypill" combining three medications recommended to treat heart failure into a single daily dose proved far more effective for patients than taking the drugs separately, a randomized clinical trial led by UT Southwestern Medical Center researchers sho…
AI Summary: The POLY‑HF randomized trial found that a fixed‑dose 'polypill' for heart failure with reduced ejection fraction cut hospitalizations and emergency visits by roughly 60%, improving adherence and standardizing therapy. Results suggest a pragmatic, low‑complexity intervention could deliver substantial health‑system benefits if adopted broadly and monitored for implementation challenges.
Related Stories
Mount Sinai and Anthem reach three‑year in‑network agreement / 2 months
Analysis finds small patient group drives majority of admissions and costs / 3 months
Kaiser Permanente strike ends with tentative agreement on staffing and pay / 4 months
Pharmacies prevail as Florida hospitals lose $2B opioid lawsuit / 4 wks
Hospitals push regulators to block expanded 340B claims reporting requirements / 3 months
CMS tightens oversight of accrediting bodies and consulting limits / 17 days
RN turnover nearly doubled since pandemic, alarming hospital leaders / 19 days
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Neuroscience, Medicaid, Vaccine Safety, Adolescent Health and look for the RSS link.
StackHealth Time Machine